Cubist Systematic Strategies’s GoHealth GOCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,915
Closed -$134K 3180
2025
Q1
$134K Buy
10,915
+8,168
+297% +$125K ﹤0.01% 2590
2024
Q4
$36.8K Buy
+2,747
New +$31.2K ﹤0.01% 2809
2022
Q2
Sell
-17,776
Closed -$315K 4424
2022
Q1
$315K Buy
17,776
+5,877
+49% +$183K ﹤0.01% 2815
2021
Q4
$676K Sell
11,899
-16,561
-58% -$1.11M 0.01% 2216
2021
Q3
$2.15M Buy
28,460
+26,392
+1,276% +$2.79M 0.03% 965
2021
Q2
$348K Sell
2,068
-14,842
-88% -$2.6M ﹤0.01% 2243
2021
Q1
$2.96M Buy
16,910
+16,260
+2,502% +$3.28M 0.04% 763
2020
Q4
$133K Buy
650
+438
+207% +$81.3K ﹤0.01% 2360
2020
Q3
$41K Buy
+212
New +$51K ﹤0.01% 2379

Other funds holding GOCO

Cubist Systematic Strategies's GOCO Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of GoHealth (GOCO) in Q2 2025, closing a stake of 10,915 shares — an estimated $134K sold.

Cubist Systematic Strategies first reported a position in GOCO in Q3 2020 and held it in 9 quarters. The position peaked at $2.96M in Q1 2021. 55 funds tracked by Wall St. Rank hold GOCO as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining GoHealth position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 10,915 GoHealth shares in Q2 2025, an estimated $134K.
  • Cubist Systematic Strategies first reported a position in GoHealth in Q3 2020 and held it in 9 quarters.
  • Cubist Systematic Strategies's GoHealth position peaked at $2.96M in Q1 2021.
  • 55 funds tracked by Wall St. Rank held GoHealth as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.